On March 11, 2016 at 10th European Breast Cancer Conference (EBCC-10) Cromos Pharma's team will present the results of a large epidemiologic study that examined the discrepancies in treatment patterns and in access to care among 48 regions of the Russian Federation (poster #111, abstract #472).
This study was made possible through the grant of "Stand Up to Cancer" foundation and was conducted by the NGO "National Center for Technology Assessment in Health Care" in collaboration with Cromos Pharma.
"This is the first independent look at breast cancer care in Russia since the fall of the Soviet Union", said Dr. Bogin, MD, FACP, Cromos Pharma's CEO. "The study reveals some eye-opening discrepancies both in treatment algorithms and in access to care between various regions of Russia".
"We were very excited to participate in this much needed study", said Dr. Maria Avksentieva, MD, PhD, Professor of Epidemiology at the First Moscow State Medical University. "We hope that the results of the study will influence policy decisions when it comes to physician training, state and regional funding".
We will be glad to discuss the study results during the conference - see you in Amsterdam on March 9-11, 2016!